Literature DB >> 19937360

Good maternal and fetal outcomes of predominantly sensory Guillain-Barré syndrome in pregnancy after intravenous immunoglobulin.

Yasuo Matsuzawa1, Ryuji Sakakibara, Toshiko Shoda, Masahiko Kishi, Emina Ogawa.   

Abstract

Guillain-Barré syndrome (GBS)-complicating pregnancy is rare; and it is generally believed that it carries a high maternal risk. We reported a case of good maternal and fetal outcomes of predominantly sensory GBS (generalized pain and numbness, mild deep sensory ataxia, positive serum IgM anti-GalNAcGD1a antibody)-complicating pregnancy after intravenous immunoglobulin treatment.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19937360     DOI： 10.1007/s10072-009-0188-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  13 in total

1.  Acute inflammatory demyelinating polyneuropathy in patients with pregnancy.

Authors:  V Goyal; B K Misra; S Singh; K Prasad; M Behari
Journal:  Neurol India       Date:  2004-06       Impact factor: 2.117

2.  Does sensory Guillain-Barré syndrome exist without any abnormalities in motor nerve conduction?

Authors:  Sang-Soo Lee; Sung-Hyun Lee
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

3.  [Severe Guillain-Barré syndrome and pregnancy: two cases with rapid improvement post-partum].

Authors:  C Vaduva; J de Seze; A-C Volatron; T Stojkovic; S Piechno; J Husson; P Vermersch; A Furby
Journal:  Rev Neurol (Paris)       Date:  2006-03       Impact factor: 2.607

Review 4.  Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.

Authors:  Ralf Gold; Martin Stangel; Marinos C Dalakas
Journal:  Nat Clin Pract Neurol       Date:  2007-01

5.  Acquired demyelinating polyneuropathy presenting as a pure clinical sensory syndrome.

Authors:  Z Simmons; S Tivakaran
Journal:  Muscle Nerve       Date:  1996-09       Impact factor: 3.217

6.  Acute small fibre sensory neuropathy: another variant of Guillain-Barré syndrome?

Authors:  U Seneviratne; S Gunasekera
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 7.  Immunotherapy for Guillain-Barré syndrome: a systematic review.

Authors:  Richard A C Hughes; Anthony V Swan; Jean-Claude Raphaël; Djillali Annane; Rinske van Koningsveld; Pieter A van Doorn
Journal:  Brain       Date:  2007-03-02       Impact factor: 13.501

8.  Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection.

Authors:  Kazue Ogawara; Satoshi Kuwabara; Michiaki Koga; Masahiro Mori; Nobuhiro Yuki; Takamichi Hattori
Journal:  J Neurol Sci       Date:  2003-06-15       Impact factor: 3.181

Review 9.  Guillain-Barré syndrome in pregnancy.

Authors:  Louis Yik-Si Chan; Michelle Hang-Yuet Tsui; Tse Ngong Leung
Journal:  Acta Obstet Gynecol Scand       Date:  2004-04       Impact factor: 3.636

10.  Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.

Authors:  Satoshi Kuwabara; Miho Nakata; Jia-Ying Sung; Masahiro Mori; Naoko Kato; Takamichi Hattori; Michiaki Koga; Nobuhiro Yuki
Journal:  J Neurol Sci       Date:  2002-07-15       Impact factor: 3.181
View more
  1 in total

1.  Guillain-Barré syndrome in pregnancy: A case report.

Authors:  Misai Hukuimwe; Tawanda T Matsa; Muchabayiwa F Gidiri
Journal:  Womens Health (Lond)       Date:  2017-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.